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IT IS generally agreed that ageing
appears to be a strong determinant of
cancer incidence (Doll et al., 1970; Teller,
1972; Peto et al., 1975). This suggests that
the steps leading to malignant trans-
formation accumulate over many years.
Environmental factors are particularly
determining for carcinogenesis, but the
exact role played by transforming agents
such as carcinogens and viruses, and by
the adaptive capacity of host defense
mechanisms such as innate spontaneous
resistance, or acquired immunologically
specific response, remains to be deter-
mined. In recent years, the classic con-
cept of immunological surveillance as an
acquired, thymus-dependent, immune
mechanism capable of efficiently destroy-
ing tumours in sita has been challenged
by various observations (Moller, 1976;
Stutman, 1977). On the other hand, evi-
dence is increasing, which suggests that a
variety of cellular and humoral inborn
mechanisms may considerably contribute
to tumour resistance. Among these, the
possiblerole ofmononuclearphagocyteshas
thusfarbeen investigated most thoroughly
(Nelson,1976; Fink, 1976; James et al.,
1977). In rodents, the capacity ofadherent,
predominantly phagocytic, mononuclear
cells to express cytotoxicity against
diverse target cells in vitro is already fully
developed a few days after birth, is then
more or less preserved over a period of
several months, but is clearly reduced in
senescence (Keller, 1978b). I report here,
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not only that the in vivo resistance of
rats to the inoculation of carcinogen-
induced fibrosarcoma ascites tumour cells
shows a similar age dependence, but also
that, even in old rats with greatly dimin-
ished spontaneous resistance, the capacity
to increase tumour resistance on inocula-
tion of Corynebacterium parvum organisms
still exists.
A typical experiment presented in the
Figure shows that spontaneous resistance
to a carcinogen-induced DA rat fibro-
sarcoma of low immunogenicity, growing
in ascites form (Keller, 1977a), was highest
in the youngest age group examined
(i.e. in rats of 30 days), was slightly lower
in rats of 3-4 months, and was consistently
distinctly reduced in rats of 12 and 16-18
months of age, and was thus quite inde-
pendent of the actual body weight (Fig.).
A similar decrease in spontaneous resis-
tance to this particular tumour with
increasing age has been ascertained in 7
further, similar experiments. These in
vivo findings are in keeping with the
growth characteristics of some tumours
(Teller, 1972; Zinzar et al., 1976), but
differ from those ofother tumours (Kutner
& Southam, 1960; Adams et al., 1967;
Forberg & Staffan, 1969; Forni & Como-
glio, 1973).
To investigate the thesis that the well-
documented capacity to efficiently
stimulate antitumour resistance showed
a comparable age dependence, DA rats
of different ages were given heat-killedR. KELLER
FIG.-Age dependence ofspontaneous tumour
resistance in rats and its stimulation by C.
parvum. DA rats were inoculated i.p. with
103 syngeneic DMBA-induced tumour cells
(DMBA-12; Keller, 1977a) on Day 0, and
the survival of the animals recorded.
Groups of rats were given heat-killed C.
parvum organisms on Day -7 (3mg/rat i.p.
strain 2683, Institut Pasteur) which were
cultured and harvested as described in
(Keller, 1977a). Ordinate: number of rats
remaining alive. Abscissa: days after i.p.
inoculation of tumour cells. Age groups:
0 30 days (initial mean weight 95 g); C1
3-4 months (178 g); A 12 months (292 g);
0 16-18 months (312 g). Open symbols:
rats inoculated with tumour cells only.
Closed symbols: rats pretreated with C.
parvum i.p. on Day -7, and challenged
with tumour cells on Day 0. Statistical
analysis of the data revealed that, within
each age group, the differences between
controls and C. parvum-treated animals
were highly significant (P < 0-001 in the 4
t tests). The survival time of controls of 30
days and/or 3-4 months was significantly
longer (P < 0-001) than in older mice; in
the C. parvum-treated rats, no differences
in the survival time were detected between
the different age groups (one-way analysis
of variance).
C. parvum before tumour challenge. Data
such as those in the Figure demonstrate
that the potential to increase the host's
local antitumour resistance on i.p. inocula-
tion of C. parvum organisms, was roughly
similar in rats of 30 days and 3-4 months;
in both age groups, C. parvum treatment
was well supported and the survival time
after the inoculation of tumour cells was
significantly prolonged. Pretreatment
with C. parvum was distinctly more toxic
for rats aged 12 m, and 16-18 m, and
caused the loss of20-30% ofthese animals
within 10 days. In rats of 12 and 16-18
months and surviving the C. parvum
treatment, resistance to the tumour chal-
lenge varied within a large range. In 5
out of 6 experiments, pretreatment with
C. parvum caused a distinct enhancement
of local tumour resistance which was
sometimes even more pronounced than in
younger animals (Fig.); in one experiment,
only minor stimulatory effects were detec-
table.
The spontaneous cytotoxicity expressed
in vitro against a variey of syngeneic,
allogeneic and xenogeneic target cells has
been found to be associated with adherent,
predominantly phagocytic, mononuclear
cells which were selectively eliminated by
silica particles (Keller, 1978a). On the
basis of these properties, and the differ-
ences in the time required to express
cytotoxicity (Keller, 1977b), in their
distribution at diverse anatomical sites of
various strains of rats and mice (Keller,
1978a), and in the age pattern of the
cytolytic potential (Keller, 1978b) it has
been concluded that these macrophage-
like effectors are different from other cells
with inherent cytolytic capacity, such as
T and B cells, K or NK cells (Goodman &
Makinodan, 1975; Nathan et al., 1977;
Herberman et al., 1978; Kiessling &
Haller, 1978; Keller, 1977b; Brunner et al.,
1970).
Previous in vivo findings have shown
that spontaneous tumour resistance is
significantly reduced by agents which
interfere with macrophage functions in
vitro, such as silica particles (Keller, 1976)
carrageenan (Keller, 1976; Thomson &
Fowler, 1977) or gold salts (McBride
et al., 1975). Moreover, the well-known
antitumour effect of bacterial adjuvants,
such as BCG or C. parvum, was abrogated
by silica particles (Keller, 1977a; Hopper
et al., 1976) carrageenan (Keller, 1977a)
or gold salts (McBride et al., 1975). There
is evidence that under in vivo conditions
the effects of antimacrophage agents
(Keller, 1976; Bennett et at., 1976) and
ofimmunostimulants (Laucius et al., 1974;
Scott, 1974; Ojo et al., 1978) are manifold
and can affect the response of T and B
lymphocytes, of mononuclear phagocytes
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and of NK cells. Therefore, the present
data do not help to identify the cell
system(s) contributing to antitumour re-
sistance.
In summary, in the present in vivo rat
fibrosarcoma model system, spontaneous
resistance to the tumour is high early
after birth, gradually declining with
increasing age, and is markedly diminished
in senescence. In sharp contrast, the anti-
tumour effect of C. parvum operates not
only in the very young rat already
showing high spontaneous resistance to
the tumour, but is often fully preserved
in senescent rats with markedly reduced
natural tumour resistance. The present
demonstration that the weakened spon-
taneous antitumour resistance character-
istic of the elderly host can be effectively
enhanced locally by appropriate agents,
i.e. that the mechanisms expressing such
resistance are still preserved, seems parti-
cularly relevant.
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